Integra LifeSciences

ISIN US4579852082

 | 

WKN 897013

Market cap (in EUR)
874 m
Country
United States
Sector
Healthcare
Dividend yield
0.00%
 

Overview

Description

Integra LifeSciences Holdings Corp. engages in the provision of regenerative tissue technologies and neurological solutions dedicated to limiting uncertainty for clinicians. It operates under the Codman Specialty Surgical (CSS) and Tissue Technologies (TT) segments. The CSS segment includes technologies and instrumentation used for neurosurgery, neurocritical care, and otolaryngology. The TT segment focuses on complex wound surgery, surgical reconstruction, and peripheral nerve repair. The company was founded by Richard E. Caruso in 1989 and is headquartered in Princeton, NJ.
Show more Show less
Healthcare Healthcare Equipment Other Medical Devices United States

Financials

Key metrics

Market capitalisation, EUR 874 m
EPS, EUR -5.85
P/B ratio 1.0
P/E ratio 63.6
Dividend yield 0.00%

Income statement (2024)

Revenue, EUR 1,489 m
Net income, EUR -6 m
Profit margin -0.43%

What ETF is Integra LifeSciences in?

There are 2 ETFs which contain Integra LifeSciences. All of these ETFs are listed in the table below. The ETF with the largest weighting of Integra LifeSciences is the iShares S&P SmallCap 600 UCITS ETF.
ETF Weight Investment focus Fund size (in m EUR)
iShares S&P SmallCap 600 UCITS ETF 0.05%
Equity
United States
Small Cap
1,769
JPMorgan BetaBuilders US Small Cap Equity UCITS ETF USD (dist) 0.01%
Equity
United States
Small Cap
183
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.

Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.